Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic
DBCAT004012Therapeutic category
A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of August 19, 2018
Which targets do Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account